Shares of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) rallied as much as 3% on Thursday on renewed speculation that the company could be a takeover target. Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company, primarily focuses on oncology and hematology. The company engages in acquiring, developing, and commercializing a broad and diverse pipeline of late-stage clinical and commercial products. The company will release its second quarter earnings on August 4, 2011.
Full Disclosure: None.
Full Disclosure: None.
